SCHEMBL30798844

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	MAPK8	P45983	1/20	0.61

▸	MAPK9	P45984	1/20	0.61

▸	MAPK10	P53779	1/20	0.61

▸	RAMP3	O60896	13/20	0.58

▸	CALCR	P30988	13/20	0.58

▸	KDM1A	O60341	1/20	0.57

▸	NPY2R	P49146	5/20	0.57

▸	NPY4R	P50391	5/20	0.57

▸	NPY5R	Q15761	5/20	0.57

▸	NPY1R	P25929	3/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL23273245	0.94	MAPK8 (0.61)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL29456270	0.87	KDM1A (0.59)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL31031615	0.87	RAMP3 (0.56)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL30980909	0.85	MAPK8 (0.64)	MAPK8MAPK9MAPK10CALCRKDM1A
SCHEMBL30980911	0.85	MAPK8 (0.63)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL30432784	0.84	KDM1A (0.58)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL30360051	0.84	MAPK8 (0.58)	MAPK8MAPK9MAPK10RAMP3CALCR
SCHEMBL31182511	0.84	RAMP3 (0.62)	RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL31663834	0.84	RAMP3 (0.58)	RAMP3CALCRNPY2RNPY4RNPY5R
SCHEMBL30702386	0.84	KDM1A (0.60)	MAPK8MAPK9MAPK10RAMP3CALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-11911451-B2	Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers	ImmuLogix Ltd (US)	2024-02-27	—	—	US	disclosed